SG11202102682SA - Quinoline derivative used for treating small cell lung cancer - Google Patents
Quinoline derivative used for treating small cell lung cancerInfo
- Publication number
- SG11202102682SA SG11202102682SA SG11202102682SA SG11202102682SA SG11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA SG 11202102682S A SG11202102682S A SG 11202102682SA
- Authority
- SG
- Singapore
- Prior art keywords
- lung cancer
- small cell
- cell lung
- derivative used
- quinoline derivative
- Prior art date
Links
- 206010041067 Small cell lung cancer Diseases 0.000 title 1
- 125000002943 quinolinyl group Chemical class N1=C(C=CC2=CC=CC=C12)* 0.000 title 1
- 208000000587 small cell lung carcinoma Diseases 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811088089 | 2018-09-18 | ||
PCT/CN2019/106406 WO2020057539A1 (zh) | 2018-09-18 | 2019-09-18 | 用于治疗小细胞肺癌的喹啉衍生物 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202102682SA true SG11202102682SA (en) | 2021-04-29 |
Family
ID=69888373
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202102682SA SG11202102682SA (en) | 2018-09-18 | 2019-09-18 | Quinoline derivative used for treating small cell lung cancer |
Country Status (7)
Country | Link |
---|---|
US (1) | US20220031689A1 (zh) |
EP (1) | EP3854396A4 (zh) |
CN (3) | CN117085016A (zh) |
AU (1) | AU2019344764A1 (zh) |
CA (1) | CA3112946A1 (zh) |
SG (1) | SG11202102682SA (zh) |
WO (1) | WO2020057539A1 (zh) |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8148532B2 (en) | 2007-03-14 | 2012-04-03 | Guoqing Paul Chen | Spiro substituted compounds as angiogenesis inhibitors |
CN102344438B (zh) | 2010-08-01 | 2014-02-19 | 正大天晴药业集团股份有限公司 | 喹啉衍生物的结晶及其制备方法 |
CN105311030B (zh) * | 2014-06-06 | 2020-03-24 | 正大天晴药业集团股份有限公司 | 用于抗肿瘤的螺取代化合物 |
CN114652723A (zh) * | 2014-12-09 | 2022-06-24 | 正大天晴药业集团股份有限公司 | 治疗非小细胞肺癌的喹啉衍生物 |
US9751859B2 (en) * | 2015-05-04 | 2017-09-05 | Advenchen Pharmaceuticals, LLC | Process for preparing an anti-cancer agent, 1-((4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxyquinolin-7-yloxy)methyl)cyclopropanamine, its crystalline form and its salts |
-
2019
- 2019-09-18 CN CN202311015937.1A patent/CN117085016A/zh active Pending
- 2019-09-18 WO PCT/CN2019/106406 patent/WO2020057539A1/zh active Application Filing
- 2019-09-18 EP EP19861634.4A patent/EP3854396A4/en active Pending
- 2019-09-18 CN CN201980052510.4A patent/CN112533600B/zh active Active
- 2019-09-18 CA CA3112946A patent/CA3112946A1/en active Pending
- 2019-09-18 SG SG11202102682SA patent/SG11202102682SA/en unknown
- 2019-09-18 AU AU2019344764A patent/AU2019344764A1/en active Pending
- 2019-09-18 CN CN202311015952.6A patent/CN117085017A/zh active Pending
- 2019-09-18 US US17/276,972 patent/US20220031689A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US20220031689A1 (en) | 2022-02-03 |
WO2020057539A1 (zh) | 2020-03-26 |
EP3854396A4 (en) | 2022-06-29 |
CN117085016A (zh) | 2023-11-21 |
CN112533600A (zh) | 2021-03-19 |
CN117085017A (zh) | 2023-11-21 |
AU2019344764A1 (en) | 2021-05-20 |
EP3854396A1 (en) | 2021-07-28 |
CN112533600B (zh) | 2023-07-14 |
CA3112946A1 (en) | 2020-03-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3641770A4 (en) | METHOD OF TREATMENT OF CANCER | |
EP3443119B8 (en) | Methods for lung cancer detection | |
EP3488001A4 (en) | TREATMENT OF CANCER | |
EP3307876A4 (en) | NK-92 CELLS MODIFIED TO TREAT CANCER | |
EP3288382A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
HK1251862A1 (zh) | 治療癌症的方法和組合物 | |
EP3400010A4 (en) | ANTI-HER2 COMBINATIONS FOR THE TREATMENT OF TUMORS | |
IL275337A (en) | 1-(piperidinocarbonylmethyl)-2-oxopyrazine derivatives for cancer therapy | |
EP3092006A4 (en) | Targeted therapy for small cell lung cancer | |
EP3407978A4 (en) | COMBINATION THERAPY FOR TREATING CANCER | |
EP3606962A4 (en) | TREATMENT METHODS FOR HIGH CD73 TUMORS | |
EP3285773A4 (en) | POLY THERAPY FOR THE TREATMENT OF CANCER | |
EP3405203A4 (en) | METHODS OF TREATING CANCER | |
EP3440112A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
EP3389634A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
EP3341080A4 (en) | METHOD FOR THE TREATMENT OF CANCER | |
HK1252370A1 (zh) | 用於治療非小細胞肺癌的治療方法和組合物 | |
IL255079A0 (en) | Methods of treating lung cancer | |
EP3389652A4 (en) | METHODS OF TREATING CANCER | |
EP3443962A4 (en) | QUINOLINE DERIVATIVE FOR THE TREATMENT OF ESTOMAC CANCER | |
IL287907A (en) | Cancer treatment methods | |
EP3589659A4 (en) | CANCER TREATMENT COMPOUNDS AND METHODS | |
EP3892282A4 (en) | COMBINATIONS FOR TREATING CANCER | |
EP3713576A4 (en) | CANCER TREATMENT METHODS | |
EP3260119A4 (en) | Combination method for treating cancer |